Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug Outcomes

doi:10.1001/jamapsychiatry.2017.4704

Editorial

. 2018 Apr 1;75(4):314-315.

doi: 10.1001/jamapsychiatry.2017.4704.

Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug Outcomes

Stefan Leucht¹, John M Davis^{2

3}

Affiliations

¹ Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany.
² Psychiatric Institute, University of Illinois, Chicago.
³ Maryland Psychiatric Research Center, Baltimore.

PMID: 29490368
DOI: 10.1001/jamapsychiatry.2017.4704

Editorial

Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug Outcomes

Stefan Leucht et al. JAMA Psychiatry. 2018.

. 2018 Apr 1;75(4):314-315.

doi: 10.1001/jamapsychiatry.2017.4704.

Authors

Stefan Leucht¹, John M Davis^{2

3}

Affiliations

¹ Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany.
² Psychiatric Institute, University of Illinois, Chicago.
³ Maryland Psychiatric Research Center, Baltimore.

PMID: 29490368
DOI: 10.1001/jamapsychiatry.2017.4704

No abstract available

PubMed Disclaimer

Comment on

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
Lähteenvuo M, Tanskanen A, Taipale H, Hoti F, Vattulainen P, Vieta E, Tiihonen J. Lähteenvuo M, et al. JAMA Psychiatry. 2018 Apr 1;75(4):347-355. doi: 10.1001/jamapsychiatry.2017.4711. JAMA Psychiatry. 2018. PMID: 29490359 Free PMC article.

Cited by

Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry.
Stip E, Javaid S, Bayard-Diotte J, Abdel Aziz K, Arnone D. Stip E, et al. Ther Adv Psychopharmacol. 2020 Sep 13;10:2045125320957118. doi: 10.1177/2045125320957118. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 32974000 Free PMC article.
Evaluation of Differences in Individual Treatment Response in Schizophrenia Spectrum Disorders: A Meta-analysis.
Winkelbeiner S, Leucht S, Kane JM, Homan P. Winkelbeiner S, et al. JAMA Psychiatry. 2019 Oct 1;76(10):1063-1073. doi: 10.1001/jamapsychiatry.2019.1530. JAMA Psychiatry. 2019. PMID: 31158853 Free PMC article.
Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.
Chang Z, Ghirardi L, Quinn PD, Asherson P, D'Onofrio BM, Larsson H. Chang Z, et al. Biol Psychiatry. 2019 Sep 1;86(5):335-343. doi: 10.1016/j.biopsych.2019.04.009. Epub 2019 Apr 17. Biol Psychiatry. 2019. PMID: 31155139 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug Outcomes

Affiliations

Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug Outcomes

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical